These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 36368348)

  • 1. Outcomes of Over 1000 Heart Transplants Using Hepatitis C-Positive Donors in the Modern Era.
    Kwon JH; Hill MA; Patel R; Tedford RJ; Hashmi ZA; Shorbaji K; Huckaby LV; Welch BA; Kilic A
    Ann Thorac Surg; 2023 Feb; 115(2):493-500. PubMed ID: 36368348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Racial and Gender Disparities in Transplantation of Hepatitis C+ Hearts and Lungs.
    Hannan HA; Goldberg DS
    J Heart Lung Transplant; 2024 May; 43(5):780-786. PubMed ID: 38163451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lung Transplantation from hepatitis C+ donor lungs: Reassuring midterm outcomes.
    Kim ST; Xia Y; Ho JK; Lowery E; McCarthy DP; Ardehali A
    J Heart Lung Transplant; 2024 Feb; 43(2):337-345. PubMed ID: 37866469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increasing multiorgan heart transplantation with hepatitis C virus donors in the current-era.
    Madan S; Patel SR; Vlismas P; Hemmige V; Saeed O; Goldstein DJ; Jorde UP
    J Heart Lung Transplant; 2021 Nov; 40(11):1382-1386. PubMed ID: 34176726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early Assessment of Cardiac Allograft Vasculopathy Risk Among Recipients of Hepatitis C Virus-infected Donors in the Current Era.
    Amancherla K; Feurer ID; Rega SA; Cluckey A; Salih M; Davis J; Pedrotty D; Ooi H; Rali AS; Siddiqi HK; Menachem J; Brinkley DM; Punnoose L; Sacks SB; Zalawadiya SK; Wigger M; Balsara K; Trahanas J; McMaster WG; Hoffman J; Pasrija C; Lindenfeld J; Shah AS; Schlendorf KH
    J Card Fail; 2024 May; 30(5):694-700. PubMed ID: 37907147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C virus seropositivity in organ donors and survival in heart transplant recipients.
    Gasink LB; Blumberg EA; Localio AR; Desai SS; Israni AK; Lautenbach E
    JAMA; 2006 Oct; 296(15):1843-50. PubMed ID: 17047214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utilization rates and clinical outcomes of hepatitis C positive donor hearts in the contemporary era.
    Madan S; Patel SR; Rahgozar K; Saeed O; Murthy S; Vukelic S; Sims DB; Shin JJ; Goldstein DJ; Jorde UP
    J Heart Lung Transplant; 2019 Sep; 38(9):907-917. PubMed ID: 31495408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Varying Utilization Rates but Superior Outcomes in Liver Transplantation From Hepatitis C-positive Donors in the United States: An Analysis of the OPTN/UNOS Database.
    Bekki Y; Crismale JF; Myers B; Schiano TD; Florman S
    Transplantation; 2022 Sep; 106(9):1787-1798. PubMed ID: 35507448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early Outcomes of Adult Heart Transplantation From COVID-19 Infected Donors.
    Madan S; Chan MAG; Saeed O; Hemmige V; Sims DB; Forest SJ; Goldstein DJ; Patel SR; Jorde UP
    J Am Coll Cardiol; 2023 Jun; 81(24):2344-2357. PubMed ID: 37204379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in the use of hepatitis C viremic donor hearts.
    Li SS; Osho A; Moonsamy P; D'Alessandro DA; Lewis GD; Villavicencio MA; Sundt TM; Funamoto M
    J Thorac Cardiovasc Surg; 2022 May; 163(5):1873-1885.e7. PubMed ID: 33487431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of Adult Heart Transplantation Using Hepatitis C-Positive Donors.
    Kilic A; Hickey G; Mathier M; Sultan I; Gleason TG; Horn E; Keebler ME
    J Am Heart Assoc; 2020 Jan; 9(2):e014495. PubMed ID: 31910781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DCD Hepatitis C Virus-positive Donor Livers Can Achieve Favorable Outcomes With Liver Transplantation and Are Underutilized.
    Myers B; Bekki Y; Kozato A; Crismale JF; Schiano TD; Florman S
    Transplantation; 2023 Mar; 107(3):670-679. PubMed ID: 36398318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. National trends and outcomes of heart-kidney transplantation using hepatitis C positive donors.
    Diaz-Castrillon CE; Huckaby LV; Witer L; Pope NH; Katz MR; Baliga PK; Kilic A
    Clin Transplant; 2022 Apr; 36(4):e14581. PubMed ID: 34974630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of hepatitis C virus seropositive donors to hepatitis C virus seronegative liver recipients: A large single center analysis.
    Sobotka LA; Mumtaz K; Wellner MR; Kelly SG; Conteh LF; Hanje AJ; Schenk A; El-Hinnawi A; Black S; Washburn K; Pesavento T; Daloul R; Michaels AJ
    Ann Hepatol; 2021; 24():100318. PubMed ID: 33515801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utilization of hepatitis C virus infected donors in heart transplant recipients with elevated MELD-XI score.
    Hirani R; Okumura K; Isath A; Gregory V; Khan S; Dhand A; Lanier GM; Spielvogel D; Kai M; Ohira S
    Clin Transplant; 2023 Dec; 37(12):e15124. PubMed ID: 37688341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association of donor hepatitis C virus infection with 3-year kidney transplant outcomes in the era of direct-acting antiviral medications.
    Sutcliffe S; Ji M; Chang SH; Stewart D; Axelrod DA; Lentine KL; Wellen J; Alrata L; Gupta G; Alhamad T
    Am J Transplant; 2023 May; 23(5):629-635. PubMed ID: 37130619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of Lung Transplantation From Hepatitis C Viremic Donors.
    Li SS; Osho A; Moonsamy P; Wolfe S; Villavicencio MA; Langer N; Sundt TM; Funamoto M
    Ann Thorac Surg; 2022 May; 113(5):1598-1607. PubMed ID: 34062125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utilization of Organs From Donors According to Hepatitis C Antibody and Nucleic Acid Testing Status: Time for Change.
    Kling CE; Perkins JD; Landis CS; Limaye AP; Sibulesky L
    Am J Transplant; 2017 Nov; 17(11):2863-2868. PubMed ID: 28688205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Hepatitis C Virus Infection on Heart Transplants in the Current Era.
    Fujisaki T; Mikami T; Kuno T; Moss N; Itagaki S
    Transplantation; 2021 Nov; 105(11):2482-2489. PubMed ID: 33496557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of using hepatitis c virus nucleic acid test-positive donor hearts on heart transplant waitlist time and transplant rate.
    Gernhofer YK; Brambatti M; Greenberg BH; Adler E; Aslam S; Pretorius V
    J Heart Lung Transplant; 2019 Nov; 38(11):1178-1188. PubMed ID: 31492607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.